Eccrine hidrocystoma
☆ An den 2022 Stiftung Warentest Resultater aus Däitschland war d'Zefriddenheet vum Konsument mam ModelDerm nëmme liicht manner wéi mat bezuelte Telemedizin Konsultatiounen.
Et presentéiert sech als kleng blo Papel gefëllt mat kloer Flëssegkeet.
References
Eccrine hidrocystomas (EHs) si benigne Tumoren déi sech aus geschwollen eccrine Schweesskanal bilden. Si daueren dacks laang a kënne bei waarme Wieder verschlechtert ginn wann d'Schweess eropgeet. EH gëtt normalerweis op Basis vu Symptomer diagnostizéiert, awer eng Hautbiopsie kann et bestätegen. Mir presentéieren zwee Fäll vun EH, konzentréieren op hir dermoscopic Fonctiounen an erfollegräich Behandlung mat topical botulinum toxin-ähnlechen peptide.
Eccrine hidrocystomas (EHs) are benign tumors, which arise as cystic dilatation of the eccrine sweat duct. The lesions of EH have a chronic course with periodic flares in summer months, associated with exacerbation in sweating. Diagnosis is mainly clinical with histopathology being confirmatory. Dermoscopy is a noninvasive tool, which may confirm diagnosis of EH without subjecting the patient to a biopsy. We report two representative cases of EH, with emphasis on dermoscopic features and which well responded to topical botulinum toxin-like peptide.
Eccrine hidrocystomas (EHs) are benign tumors, which arise as cystic dilatation of the eccrine sweat duct. The lesions of EH have a chronic course with periodic flares in summer months, associated with exacerbation in sweating. Diagnosis is mainly clinical with histopathology being confirmatory. Dermoscopy is a noninvasive tool, which may confirm diagnosis of EH without subjecting the patient to a biopsy. We report two representative cases of EH, with emphasis on dermoscopic features and which well responded to topical botulinum toxin-like peptide.
○ Behandlung
Ofkillung vum betroffenen Gebitt kann d'Gréisst vum betroffenen Gebitt temporär reduzéieren.
Laser Behandlung ass normalerweis net effikass.